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Abstract
The implementation of a particle design platform that can be applied to novel phar-
maceutical systems using acoustic levitation (SAL) and X-ray tomography (XRT) is
discussed. Acoustic levitation was employed to provide a container-less particle design
environment for single droplet evaporation experiments. Dried particles were subject to
further visual and quantitative structural analysis using X-ray tomography to assess the
three-dimensional volume space. The workflow of the combined SAL-XRT platform
has been applied to investigate the impact of increasing HPMCK100LV concentrations
on the evaporation, drying and final particle morphology of particles from amodel phar-
maceutical formulation containing metformin and D-mannitol. The morphology and
internal structure of the formulated particles after drying are dominated by a crystalline
core of D-mannitol partially suppressed with increasing HPMCK100LV additions. The
final structure can be correlated to the observed evaporation kinetics. The characterisa-
tion of formulated metformin hydrochloride particles with increasing polymer content
demonstrated the importance of an early-stage quantitative assessment of formulation-
related particle properties. The ability to study the evolution of solid phase formation
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and its influence on the final particle morphology can enable the selection of process
conditions that deliver the desired particle structure and consequent performance by
design.
Keywords: Pharmaceutical Formulation Development, Single Droplet Evaporation,
XRT Particle Structure Analysis, Crystallisation, Acoustic Levitation
1. Introduction
Spray Drying is a one-step continuous drying and isolation process broadly applied in
the pharmaceutical and food industry to transform a liquid solution or primary particle
suspension into a dry, solid powder.[1] Entering the drying chamber, the continuous
flow is dispersed into a spray of droplets which are brought into contact with a dry hot
gaseous flow. The complex evaporation and solidification processes are dominated by
simultaneous transfer of heat, mass and momentum. The process conditions influence a
number of particle properties including particle size, shape, morphology, porosity, den-
sity and mechanical stability.[2, 3, 4, 5] Spray Drying also has the potential to produce
crystalline or amorphous materials as well as formulated systems which can be used to
achieve drug formulations with distinct performance qualities.[6, 7, 8, 9, 10, 11, 12]
The need for small-scale experimental platforms especially for continuous drying ap-
plications has previously been highlighted by academia and industry.[13] Systems for
small scale droplet drying experiments allow the characterisation of the evaporation
process for individual droplets and have been used to study the influence of the com-
pound system and the process conditions on the attributes of the obtained final particles.
Monitoring the evaporation and particle evolution enables the extraction of quantitative
kinetic information that can support semi-empirical modelling of the drying process to
inform development before moving to lab-scale. Groups have been using droplet drying
experiments to investigate droplet shrinkage,[14] skin formation [15, 16, 17] and buck-
ling phenomena of droplets undergoing drying.[18, 19] Acoustic levitation provides a
containerless environment for single droplet evaporation experiments with a minimised
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risk for heterogeneous nucleation events and conductive heat transfer compared to simi-
lar experiments with individual droplets suspended on a filament. Quasi-stationary lev-
itated droplets can be monitored to study liquid evaporation and particle formation pro-
cesses. Applications utilising acoustic levitation to study single droplet evaporation or
to perform single particle experiments of various compound systems have been reported
in detail in the literature.[17, 20, 21, 22, 23, 24, 25, 26] The particles from such exper-
iments can be assessed in terms of their critical solid state properties and performance.
Optimisation of these particle properties through a deep understanding of the solid for-
mation process is a key objective of particle engineering. Control or improvement of
material-handling in the manufacturing process and the enhancment of product perfor-
mance linked to attributes such as mechanical stability,[26] compressability,[27, 28]
solubility[7, 29] and solid state stability[24] are just two potential areas of interest. X-
ray tomography (XRT) has been applied to a number of pharmaceutical systems for
sample visualisation and/or to extract quantitative data on particle size, surface, shape
and porosity.[30, 31, 32] XRT can be applied non-destructively to characterise a broad
range of solid samples and is not limited to individual bulk or single particle properties.
Importantly, the results of XRT analysis can be further related to the dynamics of the
solidification process observed in the single droplet evaporation experiments. The goal
of XRT analysis is increasingly moving towards relating structure to the dynamics of
solidification.[16, 19]
In this paper we demonstrate the investigation of particle formation processes using
an acoustic levitator (SAL) and the subsequent structural characterisation with XRT.
The combined SAL-XRT platform can capture and quantify time-related effects such
as evaporation kinetics, solid phase nucleation and drying rates as well as gives ac-
cess to information on the final solid structure. The SAL uses optical and thermal
imaging to monitor the evaporation process.[18, 22, 33] High-resolution XRTmeasure-
ments enable to link the particle formation process to its final morphology and internal
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structure. This bespoke approach is applied to develop a single particle formulation
for metformin hydrochloride (MET). As one of the World Health Organization’s List
of Essential Medicines, MET is widely used to treat non-insulin-dependent diabetes
mellitus.[34] In solid form, metformin is commonly available as a highly water-soluble
HCl salt and typically compressed into tablets for oral administration with high dose per
tablet of 500 mg to 1500 mg. The high drug load can cause problems during tableting
and the short biological half-life commonly requires repeated adminstrations.[35, 36]
A number of groups worked on formulated systems to produce MET-tablets with op-
timised compaction properties and/or dissolution properties to control the drug release
profile.[28, 35, 36, 37, 38] Commercial derivatives of hydroxypropyl methylcellulose
(HPMC) are frequently included in these oral controlled-release formulations and ex-
ist in various modifications and molecular sizes.[39] D-mannitol (MAN) is a common
excipient for spray drying applications and can be used in formulations for diabetes mel-
litus treatment. MAN was added as a diluent to reduce the drug-load below 50 wt%.
2. Materials and methods
2.1. Chemicals / Samples
MET andMANwere sourced from Sigma-Aldrich (St. Louis, USA). HPMCwas kindly
donated from Ashland (Benecel K100LV PH PRM, Covington, USA). Stock solutions
were prepared at concentration of 300 mg/mL for MET, 150 mg/mL for MAN, and
10 mg/mL for HPMC. The composition of each used solution is listed in Table 1. So-
lution concentrations used for the drying experiments of pure and formualted systems
were selected to achieve a comparable absolute solute mass enabling reliable imaging
and levitation. All samples were prepared with filtered and de-ionised water (Milli-Q,
Merck KGaA, Germany) and thoroughly mixed with a table vortex before usage.
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2.2. Single Axis - Acoustic Levitator
A single-axis acoustic levitator (SAL, Materials Development, Inc., Arlington Heights,
USA)was used to perform containerless single droplet evaporation experiments (Fig. 1).
The acoustic levitator has been described in detail elsewhere.[21] An additional custom-
build electric incubation system (Okolab, Naples, Italy) was employed as an enclosure
of the SAL to provide control over the surrounding temperature and humidity levels.
The enclosure consists of heated walls and windows for both imaging systems. Nitro-
gen was used as a drying gas. The nitrogen was filtered and pre-heated before entering
the chamber at 0.4 L/min. The temperature was kept constant and was constantly mea-
sured with a temperature and humidity sensor (AM2302, Adafruit Industries, USA)
integrated in the enclosure. The measured relative humidity in all experiments was less
than 2.5 %RH. The average ambient temperature in the enclosure was 42.76 ± 0.15 ◦C.
Prior to any experiments, the system was given a warm-up period of at least one hour to
reach stable conditions monitored in terms of humidity, temperature and the generated
acoustic signal.
In order to characterise the droplet evaporation process, each experiment was moni-
tored utilising a Fastcam SA1.1 high speed camera (Photron, Tokyo, Japan) and an
A6702sc thermal camera (FLIR Systems Inc., Wilsonville, USA). Images from the live
stream of the high speed camera were collected at 1 fps. The images were used to
monitor the evaporation process and to detect the onset of solid phase formation. Dur-
ing acoustic levitation, the droplet is deformed into an oblate spheroid. The volume
and surface area were calculated from the major and minor axis using an ellipse fitting
method for each image of the 2D droplet projection. The evaporation mass flux (푚̇) was
calculated iteratively from the changing droplet volume over time and is expressed in
relation to the available droplet surface area. Here, the initial point of skin formation
at the droplet lockpoint (LP) is defined by a discontinuous change of the mass flux at
the final inflection point of the droplet volume curve before reaching a constant end-
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volume. Thermal images were used to extract surface temperature information from
the droplets and particles after reaching LP. The recorded surface temperature informa-
tion can be used to identify the state of liquid evaporation at wet bulb temperature and
characterise the particle surface heating kinetics after skin formation until reaching a
stable end-temperature for the dried particle.[22, 33] The droplet surface temperature
information from thermal imaging were corrected with an emissivity factor of 0.96 for
water.[33] Following LP, the thermal emission can change depending on the character-
istic thermal radiation emitted from the solid phase composition. Therefore, the thermal
emissivity factor for each solid phase composition was estimated from the recorded tem-
perature of the particle surface after reaching a constant end-temperature level (TDry)
and the corresponding recorded ambient temperature (푇∞). The applied thermal emis-
sivity correction factors (휀) for each tested composition are listed in Table 5 (see ESI).
2.3. X-ray Tomography and XRT Image Analysis
A SKYSCAN 2211 X-ray tomograph (NanoCT, Bruker, Kontich, Belgium) with cone-
beam arrangement was employed for this project. The samples were scanned with an
image pixel size of 1.2 휇m - 1.8 휇m, frame averaging of 4 and a rotation step size of
0.2 ◦. The X-ray acceleration voltage was set to 40 keV. A reference scan was collected
at the end of each run to enhance post-alignment and compensate for potential shifts
during the scan. Image reconstruction was performed using SkyScan NRecon with
InstaRecon (version 1.7.1.6, Bruker, Kontich, Belgium).
XRT image processing was carried out with custom scripts developed in MATLAB
(MathWorks, USA). Images of each processing stage are displayed in Fig. 2. Indi-
vidual reconstructed images were pre-processed using an edge-preserving image filter
(anisotropic diffusion [40, 41]) or local low-contrast smoothing in case of HPMC to re-
duce random noise and prepare the images for subsequent binarisation (Fig. 2 a). The
binarisation was performed with a histrogram-based algoritm [42] or optimised man-
ually. Ultimately, remaining noise was removed using a size threshold of 10 voxel for
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black and white speckles and a 3D volume connectivity detection algorithm to remove
non-connected binary volumes. The pre-processed and binarised images yielded the
detected solid phase volume (V, Fig. 2 b). An additional 3D-morphological closing op-
eration with a subsequent enclosed background filter and an integrated feedback-loop
on detected internal background volumes was applied to define a region of interest for
the particle solid phase volume (V_ROI, Fig. 2 c). Extracted information of each par-
ticle are descriptors of the particle shape and its volume distribution. The absolute
particle solid phase can be quantified directly from V (Fig. 2 b). The particle porosity
(ΔV_ROI, Fig. 2 d) can be calculated from a simple subtraction of V from V_ROI. In
order to quantify concave surface volumes (ΔV_ROI_CH, Fig. 2 e) as a descriptor for
particle surface buckling, V_ROI was subtracted from the volume space of a 3D convex
hull around V_ROI.[43] The detected volumes were related to the maximum particle
space represented by a sphere with equivalent maximum Feret diameter (VeqSph,Feret)
to counter the impact of deviations in the inital droplet volume on the detected particle
volume fractions. For visualisation, image stacks were imported in CTVox (version
3.2.0, Bruker, Kontich, Belgium).
3. Results and Discussion
3.1. Solidification and Skin Formation of HPMC and formulated Systems of MET
Single droplet experiments of aHPMC solutionwith a starting concentration of 10 mg/mL
(HPMC_10, Table 1) were performed in comparison to pure water. Fig. 3 shows the
recorded normalised droplet diameter and droplet surface temperature of the evapo-
rating HPMC solution in direct comparison to pure water. Over the course of SAL
experiment, the liquid evaporation rate of HPMC droplets increasingly deviates from
the evaporation of pure water. The lockpoint (LP) due to polymer skin formation is
detected after 179.79 ± 12.93 s/mm2. After the initial skin formation the rate of water
evaporation of HPMC_10 droplets is further reduced. The permeation and evaporation
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of additional water through the polymeric surface layer leads to a radial pressure gra-
dient that causes a collapse of the particle surface inside the droplet core (SC) and the
formation of a vacuole. The generated surface enhances the evaporation of the remain-
ing moisture which causes a two-step transition to the end-temperature level as shown
in the recorded surface temperature curve after LP. Pure water droplets do not display a
discontinuous reduction in the evaporation kinetics as observed for droplets of HPMC.
The final mean diameter of six water droplet evaporation experiments was 345.43 휇푚.
Below that size a levitation of the droplets with the SAL set-up was not stable due to
secondary acoustic reflections from the enclosure.
Subsequent to the single droplet evaporation experiments, each HPMC particle was
collected and analysed using XRT to quantify the solid phase volume and extract other
structural descriptors on size, shape and particle porosity (Section 3.2). The solid phase
volume of the particles and the solid phase mass can be used to determine the solid
phase true density (Equation 1). The solid phasemass is derived from the starting solute
concentration (푐0) and the initial droplet volume (푉퐷푟표푝푙푒푡,0). The solid phase volume
(푉퐶푇 ) can be directly quantified from the XRT image data.
휌 = 푚
푉
=
푐0 ⋅ 푉퐷푟표푝푙푒푡,0
푉퐶푇
(1)
To approximate the HPMC diffusion coefficient in water, it is assumed that there is
no internal mixing and that the surface concentration of HPMC (푐푠) reaches solid true
density at LP (휌 = 휌푐푟푖푡 = 푐푠) by solving Equation 2 for a diffusion controlled sur-
face enrichment (퐸) during steady-state evaporation in accordance with the d2-law
(Equation 3) for Péclet numbers (Pe) below 20.[44, 45]
퐸 =
푐푠
푐푚
= 1 + Pe
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+ Pe2
100
+ Pe3
4000
with Pe = 휅
8 ⋅ 퐷푠
(2)
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푑2(푡) = 푑20 − 휅 ⋅ 푡 (3)
The mean solute concentration of the droplet (푐푚) can be determined from the starting
concentration of the solution and the observed absolute change in the droplet volume
at LP. The calculated solid true density (휌푐푟푖푡) and diffusion coefficient (퐷푠) from three
individual single droplet experiments are listed in Table 2. 휌푐푟푖푡 of HPMC was calcu-
lated to be 1.36 ± 0.02 g/cm3 which is in agreement with data available from literature
for other HPMC derivatives of 1.33 g/cm3.[46] Solving Equation 2 for each experiment
yields an approximated diffusion coefficient for HPMC inwater of 4.61 E-11 ± 0.26 E-11 m2/s
at a LP surface temperature of 29.18 ± 1.01 ◦Cwith an evaporation rate (휅) of 5487.10 ± 137.76 휇m2/s
and Pe of 14.92 ± 1.23. The approximated diffusion coefficient of HPMC in water is
significantly lower than the diffusion coefficients of MET and MAN reported in litera-
ture of 7.56 E-10 m2/s (29.18 ◦C, calculated see Fig. 10 (see ESI)) and 1.17 E-09 m2/s
(37 ◦C), respectively.[47, 48, 49] According to Equation 2, smaller diffusion coeffi-
cients will lead to an increase in surface enrichment. This indicates that HPMC is
expected to predominately solidify as part of the particle surface layer during skin for-
mation at LP. The comparatively high diffusion coefficients of MET and MAN allow
both small organic compounds to compensate part of their radial concentration profile
caused by liquid evaporation on the droplet surface. Therefore, MET and MAN would
be expected to predominantly solidify as part of the particle core.
The evaporation and drying of formulations of MET with MAN and HPMC (MS_0 -
MS_4, Table 1) were investigated in a series of single droplet drying experiments with
starting volumes of 9.93 ± 1.15 휇L using the SAL. Fig. 4 shows the results for three
selected formulations (MS_0, no HPMC; MS_1, low HPMC;MS_4, high HPMC). The
results indicate that the addition of HPMC significantly influences the kinetics of liquid
evaporation and particle drying after solid skin formation (LP) even at relative mass
concentrations of HPMC less than 1 wt% as in the case of MS_1. The impact of HPMC
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can be observed most dominantly during the phase of liquid evaporation with a reduced
evaporation rate and, subsequently, in a delay in the initial solid phase nucleation. The
reduced evaporation of water from the droplet surface inMS_1 andMS_4 leads to an in-
creased droplet surface temperature during liquid evaporation compared to MS_0. The
delay of LP can be observed for solutions with additions of HPMC of up to 4.5 mg/mL
(MS_4) compared to MS_0 despite a higher total solute starting concentration.
Fig. 5 shows the derived liquid evaporation mass flux and the heating rate of the par-
ticle surface during drying for the single droplet evaporation experiments presented in
Fig. 4. The droplet evaporation mass flux is calculated iteratively from the change in
droplet volume over time and normed using the available surface area. After LP, the
evaporation mass flux cannot be further tracked using a shape-based analysis of the im-
age data and, therefore, is set transparent in Fig. 5. The experienced maximum mass
flux (푚̇푚푎푥) and maximum heating rate (푇̇푚푎푥) for single droplet experiments of HPMC
and MET formulations are listed in Table 3. The maximum heating rate is the first
time-derivative of the surface temperature profile at the point of inflection undergoing
a transition from the wetbulb temperature to the final constant temperature correspond-
ing to the ambient temperature (푇퐷푟푦 = 푇∞). The results indicate that the evaporation
flux across the droplet surface is significantly reduced for droplets with additions of
HPMC and is further reduced for increasing HPMC starting concentrations. The reduc-
tion of water mass transfer prior to reaching LP supports the previous considerations
of HPMC surface enrichment with an impact on the overall water surface permeability
and evaporation. In all cases, the evaporation flux increases over time before reaching a
maximum and a subsequent discontinuous reduction due to solid skin formation at LP.
The drying rates of the particles after LP are equally reduced with increasing HPMC
concentrations which indicates decelerated mass transfer of remaining moisture to the
particle surface leading to lower drying kinetics. This could be caused by a reduction
in the water permeability through the particle surface layers due to an increasing thick-
10
ness of the polymer skin around the particle. The maximum drying rates are limited by
the accessible drying temperatures that can be applied in combination with the current
SAL setup. Work to extend this method to encompass temperature regimes that more
closely mimic those experienced across the full range of drying platforms of industrial
relevance is ongoing.
3.2. Particle Morphology Characterisation using XRT
Particles from single droplet experiments were subject to a further in-depth structural
characterisation using XRT. Fig. 6 shows the resulting particle morphologies within the
investigated particle design space during the evaporation process (SAL Image Data) and
after characterisation with XRT (XRT Image Data), respectively.
The SAL Image Data depict the moment of LP detection (top) and of the final dried
particle (bottom) for each compound (Fig. 6.1-3) as well as for five formulations of
MET with changing additions of HPMC (Fig. 6.4 a-e, MS_0 - MS_4). The SAL im-
ages allow a first visual, qualitative assessment of the final particle characteristics as
they evolve over time. Pure solutions of MET (Fig. 6.1, MET_75) and MAN (Fig. 6.2,
MAN_75) solidify as highly crystalline particles with emerging crystalline solid phase
obscuring the light transmissive droplet center at LP. In contrast, MS_0 (Fig. 6.4 a)
with a combination of equal concentrations of MET and MAN reaches LP without the
visual appearance of large structured solid primary particles. Here, the obscuration of
the droplet center occurs post-LP at elevated temperatures before reaching a fully dried
state indicating a temporary suppression of crystal nucleation for this system. This
effect is further enhanced with increasing polymer additions and several polymers in-
cluding HPMC have been shown to inhibit crystal nucleation and/or growth, although
the mechanisms are not well understood.[50] Whilst beyond the scope of this study, the
SAL-XRT platform does provide a convenient means to systematically investigate both
the onset of nucleation and the resultant difference in internal particle microstructure
for different polymer and solute formulations.
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The XRT Image Data are volume rendered visualisations of the 3D image space after
binarisation and are also included in Fig. 6 to show the particle morphology (top) as
well as the internal particle structure (bottom). Details of the internal structure for three
selected particles are displayed in Fig. 7 (a - MAN_75, b - MS_0 and c - MS_4). MET
shows large block-like solids that are agglomerated to form dense, flattened particles
(Fig. 6.1). MAN particles are highly spherical and highly porous (Fig. 6.2, details see
Fig. 7 a). The particles consist of large rod-shaped crystalline primary solids. The ob-
tained MAN particles have a similar internal structure as reported for MAN particles
from co-current spray drying at reduced evaporation kinetics using an inlet temperature
of 65 ◦C and from counter-current spray drying with extended drying times.[51, 52]
HPMC particles have smooth surfaces and large inner voids (Fig. 6.3). This morphol-
ogy has been reported previously in the literature for other large molecules such as
glycoproteins at large Péclet numbers of 5.6 and 16.8.[3]
The XRT Image Data for formulated particles of MET with MAN and HPMC (MS_0
- MS_4) are displayed in Fig. 6.4 a-e and demonstrate the impact of both excipients on
the final particle morphology. The direct comparison indicates a qualitative change in
the overall particle morphology from near sphericity to highly buckled particles with
increasing HPMC concentrations. The observed inner particle structure suggests that
the extent and size of the internal crystal core is reduced for increasing HPMC solid
mass concentrations most significantly for HPMC solid mass of 5.66 wt% (MS_3) and
10.71 wt% (MS_4). At decreasing solid mass concentrations of HPMC below 1.96 wt%
(MS_2), the rod-like crystal habit of MAN, as identified in particles from pure MAN
solution (MAN_75, Fig. 7 a), creates an inner particle structure that supports the overall
spherical morphology of the particle. This reduction in size of the rod-shaped primary
solids as part of the crystalline particle core further correlates with a decline in the
particle porosity for increasing HPMC concentrations. The drastic size reduction of
the primary, rod-shaped solids within the crystalline particle core and its impact on
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the final particle porosity are best visualised in a direct comparison for two selected
particles without the addition of HPMC (MS_0) and with a HPMC solid mass ratio of
10.71 wt% (MS_4) shown in detail in Fig. 7 b and c, respectively.
The impact of the polymer on the particle morphology and internal microstructure can
be quantified using descriptors for particle size, shape and porosity. Fig. 8 (bottom)
shows the detected volumes for the primary solid phase (V, white), the particle poros-
ity (ΔV_ROI, blue) and the detected concave surface volumes (ΔV_ROI_CH, red) for a
single cross-section of the XRT image stack from each tested formulated system (MS_0
- MS_4). In Fig. 9, the extracted quantified volumes for V, ΔV_ROI and ΔV_ROI_CH
are normalised against the volume of a sphere with equivalent maximum Feret diameter
(VeqSph,Feret) and correlated with the HPMC starting concentration. The data support
the initial visual observations for formulated MET particles with a reduction in the
particle porosity fraction of 83.59 % between MS_0 and MS_4. Detected concave sur-
face volume fractions (ΔV_ROI_CH) are proportionally higher for pure MET-MAN
(MS_0) particles compared to systems with additions of HPMC below 1.96 wt% as in
case of MS_1 and MS_2. This initial over-proportional decrease of ΔV_ROI_CH at
low HPMC concentrations can be related to a substantial changes in the particle sur-
face roughness. Here the polymer leads to a reduction in local crystal growth most
dominantly expressed in the particle surface layers. For higher HPMC concentrations,
ΔV_ROI_CH rises from its minimum of 1.11 ± 0.41 % for MS_1 to 6.16 ± 1.50 % for
MS_4 as a result of increasingly strong particle surface buckling with large concave
volumes.
In order to quantify the influence of the drug formulation on the overall particle mor-
phology, descriptors for the particle shape were extracted from the XRT data (Table 4).
The particle sphericity was calculated as a function of V_ROI and its surface area using
a definition byWadell.[53] Additionally, an aspect ratio of each particle was determined
from the major and minor characteristic axes of an ellipsoidal fit with the same normal-
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ized second central moment as V_ROI. The extracted quantitative shape descriptors re-
flect the visual impression of increased particle deformation and surface buckling with
rising concentrations of HPMC. Particles from a solution ofMET andMANwithout the
addition of HPMC (MS_0) exhibit the smallest aspect ratio with 1.20 ± 0.05 and high-
est sphericity of 0.95 ± 0.04. For formulations with HPMC (MS_1 - MS_4), the aspect
ratio and sphericity are in strong correlation with the amount of added HPMC. Changes
in the shape are most pronounced in particles with HPMC starting concentrations of
0.75 mg/mL (MS_3) and 2.25 mg/mL (MS_4). This supports the detected increase in
surface buckling for formulations with higher HPMC solid mass ratios since the gen-
erated additional particle surface and the reduced V_ROI are both directly used to cal-
culate the particle sphericity as defined by Wadell. The high deformations and surface
buckling effects of particles with HPMC solid mass ratios of 5.66 wt% and 10.71 wt%
could potentially decrease particle flowability and, therefore, manufacturability in the
downstream process. The implemented XRT image analysis capabilities are a valu-
able extension of an initial qualitative visual interpretation and offer the opportunity to
quantify key particle properties including particle size, shape and internal microstruc-
ture. The evaluation of these particle descriptors showed a strong correlation of the
particle structure to its formation process monitored on the SAL. The non-destructive
nature of the presented XRT methodologies enable a further assessment of the particle
performance characteristics i.e. undergoing dissolution or during compaction. Whilst
not explored here, these extensions of capability to 3D structure, provides a basis for
future work to develop structure-property relationships.
4. Conclusions
The reported SAL-XRT platform allows the direct measurement of single droplet drying
kinetics and the resultant particle structure as a function of solution composition. The
combined characterisation links the solid formation process to a 3D quantitative investi-
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gation of the particle. The capabilities of this platform and the developedmethodologies
for an in situ characterisation have been applied to a model pharmaceutical formulation
in order to investigate the effect of HPMC on the formation kinetics and final structure
of formulated MET particles during droplet evaporation. The reduced molecular diffu-
sion of HPMC compared withMET andMAN leads to a radial composition profile with
increasing polymer-solute ratios towards the droplet surface that in turn lower solvent
evaporation. This has implications for drying kinetic models that assume pure liquid
evaporation prior to reaching LP. Specifically, particle formation kinetics are delayed
with HPMC additions despite higher absolute solute starting concentrations.
For the MET system, XRT analysis shows a negative correlation between HPMC con-
centration and particle porosity, with the total normalised void space decreasing by
83.59 % between 0 and 10.71 wt% HPMC. Near spherical and highly buckled particles
are produced. The quantification of detected concave surface volumes revealed com-
peting effects of HPMC with an impact on the particle surface. Low concentrations of
HPMC lead to smoother surfaces compared to particles without the addition of polymer.
For higher HPMC levels, significant particle surface buckling is observed and quanti-
fied. The surface buckling itself may not only be related to the kinetics of the solid
phase formation at LP but, furthermore, to molecular interactions that cause a partial
suppression of the crystalline core. This change in the particle microstructure, its poros-
ity, surface area and surface topology can potentially effect powder flow, compaction
behaviour, dissolution and aerodynamic performance of the material.
Advanced models capable to fully describe the complex particle formation mechanisms
from solution and their dynamics need to be able to connect molecular interactions and
changing spatial compositions to the emerging solid phase structures during process-
ing. Quantitative information from an experimental assessment of the particle design
space can feed into a rational particle design approach for novel pharmaceutical sys-
tems targeted towards the control or optimisation of particle properties. The ultimate
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goal of such endeavours is to achieve desirable values for shape, porosity and/or solid
phase microstructure that can deliver the optimal performance whether during subse-
quent downstream processes or upon ultimate delivery to the patient. This work serves
as the basis of a workflow for the rapid exploration of particle formation processes.
It would be desirable to extend its application towards investigating additional formu-
lations and their impact on the final particle structure. Coupled with effective means
of performance evaluation, this approach could provide an accelerated design tool for
formulated particle systems and processes.
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Figures
Figure 1: (Left) Experimental Setup with (1) acoustic levitator with two opposed trans-
ducers and an enclosure with (1b) a sensor for measuring temperature and relative hu-
midity. The evaporation process is monitored using (2) a high speed - and (3) thermal
imaging systems. The droplets are back-illuminated with (4) an LED light source plus
diffuser. Nitrogen is filtered heated and the flow is regulated with a system from Okalab
(5 - 6). (Right) Image analysis allows the extraction of information on the droplet vol-
ume and surface temperature for the course of the evaporation process to detect initial
solid skin formation (Lockpoint, LP) and reaching a state with constant end temperature
(TDry).
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Figure 2: XRT image processing to extract quantitative descriptors for particle size,
shape, porosity and surface buckling. (1) Selected single 2D cross-section images and
(2) volume-rendered 3D image stacks with insections. (a) Grayscale images after re-
construction, (b) binarised images after thresholding and noise reduction (V), (c) region
of interest for primary particle volume (V_ROI), (d) particle porosity (ΔV_ROI) and
(e) particle concave volume (ΔV_ROI_CH).
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Figure 3: Drying curves for ( ◧ ) de-ionized water and ( ◐ ) aqueous HPMC
solution (HPMC_10, 푐0 10 mg/mL). The data show an increasing deviation of the evap-
oration kinetics for HPMC_10 compared to pure water over time and prior to the detec-
tion of skin formation (LP). After LP, the particle surface collapses (SC) before reaching
an ambient end-temperature level resulting in a two-step transition mechanism. Black
symbols - normalised squared diameter, white symbols - surface temperature. Data
from replicates with n ≥ 3.
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Figure 4: Drying curves for formulations of MET and MAN with equal starting
concentrations of 18.75 mg/mL and increasing additions of HPMC: ( ◧ ) MS_0,
푐0 0 mg/mL, ( ◐ ) MS_1, 푐0 0.375 mg/mL and ( ◭ ) MS_4, 푐0 4.5 mg/mL.
MS_0 without HPMC exhibits significantly higher evaporation kinetics compared to
MS_1 and MS_4. Black symbols - normalised squared diameter, white symbols - sur-
face temperature. Data from replicates with n ≥ 5.
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Figure 5: Solidification kinetics of formulation of MET and MAN with equal starting
concentrations of 18.75 mg/mL and varying additions of HPMC: ( ◧ ) MS_0, 푐0
0 mg/mL, ( ◐ ) MS_1, 푐0 0.375 mg/mL and ( ◭ ) MS_4, 푐0 4.5 mg/mL. The
evaporation flux increases over time and is significantly lower for droplets with added
HPMC. The drying kinetics are reduced with increasing HPMC concentrations. Black
symbols - evaporation mass flux, white symbols - surface heating rate. Data from repli-
cates with n ≥ 5.
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Figure 6: Visualisation of the investigated particle design space for solids obtained
from single droplet evaporation experiments (SAL Image Data) and after XRT charac-
terisation (XRT Image Data). The individual compounds (1-3) show distinct particle
characteristics with an impact on the particle morphology for tested formulations of
MET (MS_0 - MS_4, 4 a-e).
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Figure 7: XRT reveals the internal structure andmorphology of particles collected from
single droplet evaporation experiments of (a) pure MAN solution (MAN_75), (b) MET
formulation without HPMC (MS_0) and (c) MET formulation with 10.71 wt% HPMC
(MS_4). The cores of particles from MAN_75 solution are dominated by rod-shaped
primary crystalline solids. For formulated particles, the extent and the size of these
primary crystalline solids are significantly suppressed with increasing polymer solid
mass ratios.
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Figure 8: Selected 2D cross-sections (top - grayscale, bottom - binarised) of formulated
MET particles with MAN and increasing additions of HPMC: (a) MS_0, (b) MS_1, (c)
MS_2, (d) MS_3, (e) MS_4). The images show the detected particle volume (white),
porosity (blue) and concave surface volume (red) for the presented cross-sections after
binarisation.
29
Figure 9: Ratios of particle solid phase volume (V), particle porosity volume
(ΔV_ROI), and particle concave volume (ΔV_ROI Convex Hull) for MS_0 - MS_4.
All volumes are normalised to the volume of a sphere with equivalent maximum Feret
diameter (VeqSph,Feret).
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Tables
Table 1: Preparation schemata for solutions of metformin hydrochloride, D-mannitol
and Benecel K100LV PH PRM with sample ID and starting concentrations (푐0).
Sample 푐0,푀퐸푇[mg/mL]
푐0,푀퐴푁[mg/mL]
푐0,퐻푃푀퐶[mg/mL]
MET_75 75 - -
MAN_75 - 75 -
HPMC_10 - - 10
MS_0 18.75 18.75 -
MS_1 18.75 18.75 0.375
MS_2 18.75 18.75 0.750
MS_3 18.75 18.75 2.250
MS_4 18.75 18.75 4.500
Table 2: Calculated density of HPMC and its molecular diffusion coefficient in water
based on experimental results from three individual SAL experiments and XRT analy-
sis.
HPMC_10 푚0 [휇g] 휌푐푟푖푡 [g/cm3] 퐷푠 [10−11 m2/s]
Exp1 92.17 1.34 4.622
Exp2 92.60 1.38 4.872
Exp3 96.97 1.38 4.343
Mean 1.36 ± 0.02 4.612 ± 0.264
Table 3: Maximum mass flux (푚̇푚푎푥) and heating rate (푇̇푚푎푥) during droplet drying
experiments for HPMC (HPMC_10) and five testedMET formulations (MS_0 -MS_4).
Sample n 푚̇푚푎푥 [10−4 kg/(m2⋅s)] 푇̇푚푎푥 [◦C/s]
HPMC_10 3 9.89 ± 0.12 0.113 ± 0.006
MS_0 6 11.62 ± 0.39 0.148 ± 0.004
MS_1 8 10.12 ± 0.10 0.135 ± 0.006
MS_2 5 9.96 ± 0.23 0.131 ± 0.007
MS_3 3 9.18 ± 0.48 0.123 ± 0.006
MS_4 6 8.36 ± 0.29 0.106 ± 0.003
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Table 4: Overview of extracted shape descriptors from formulated MET particle sys-
tems MS_0 - MS_4 (n = number of particles).
Sample n Aspect Ratio Sphericity
MS_0 7 1.20 ± 0.05 0.95 ± 0.04
MS_1 8 1.96 ± 0.52 0.90 ± 0.05
MS_2 3 1.93 ± 0.28 0.89 ± 0.05
MS_3 5 2.49 ± 0.35 0.80 ± 0.05
MS_4 5 2.52 ± 0.20 0.73 ± 0.03
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Electronic Supplementary Information
Table 5: Thermal emissivity correction factors for solid phase of HPMC and formula-
tions of MET with MAN and HPMC.
휀
HPMC_10 0.988 ± 0.006
MS_0 0.942 ± 0.012
MS_1 0.929 ± 0.011
MS_2 0.936 ± 0.002
MS_3 0.949 ± 0.013
MS_4 0.932 ± 0.005
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Figure 10: 2nd degree polynomial fit to calculate the diffusion coefficient of MAN in
water. Reported experimental data from literature.[47, 48]
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